These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A case of neuroleptic malignant syndrome: in vitro muscle comparison with malignant hyperthermia. Tollefson G. J Clin Psychopharmacol; 1982 Aug; 2(4):266-70. PubMed ID: 6126494 [No Abstract] [Full Text] [Related]
3. Halothane-caffeine contracture testing in neuromuscular diseases. Heiman-Patterson TD, Rosenberg H, Fletcher JE, Tahmoush AJ. Muscle Nerve; 1988 May; 11(5):453-7. PubMed ID: 3374516 [Abstract] [Full Text] [Related]
6. Malignant hyperthermia suggestive hypermetabolic syndrome at emergence from anesthesia. Christiaens F, Gepts E, D'Haese J, Camu F. Acta Anaesthesiol Belg; 1995 May; 46(2):93-7. PubMed ID: 8714856 [Abstract] [Full Text] [Related]
7. [Current data on the screening of malignant hyperthermia during anesthesia]. Krivosic-Horber R, Adnet P. Chirurgie; 1995 May; 119(1-2):55-8. PubMed ID: 7995103 [Abstract] [Full Text] [Related]
8. An in-vivo metabolic test for detecting malignant hyperthermia susceptibility in humans: a pilot study. Schuster F, Metterlein T, Negele S, Kranke P, Muellenbach RM, Schwemmer U, Roewer N, Anetseder M. Anesth Analg; 2008 Sep; 107(3):909-14. PubMed ID: 18713904 [Abstract] [Full Text] [Related]
9. [Malignant hyperthermia: difficulty in diagnosing susceptibility in Spain]. Montes A, Ramos R, Trillo L, Silva T, Puig MM. Rev Esp Anestesiol Reanim; 1999 Mar; 46(3):130-2. PubMed ID: 10228380 [No Abstract] [Full Text] [Related]
10. In vitro contracture tests for susceptibility to malignant hyperthermia. Rosenberg H, Reed S. Anesth Analg; 1983 Apr; 62(4):415-20. PubMed ID: 6829945 [No Abstract] [Full Text] [Related]
11. Intraoperative hyperthermia in a child with neuroblastoma. Mayhew JF. Paediatr Anaesth; 2006 Aug; 16(8):890-1. PubMed ID: 16884475 [Abstract] [Full Text] [Related]
12. Malignant hyperthermia and related neuromuscular diseases: caffeine contracture of the skinned muscle fibers. Takagi A, Sunohara N, Ishihara T, Nonaka I, Sugita H. Muscle Nerve; 1983 Sep; 6(7):510-4. PubMed ID: 6633564 [Abstract] [Full Text] [Related]
13. Screening for malignant hyperthermia susceptibility. Anderson IL, Rawstron RE, Dunlop DJ. N Z Med J; 1980 Jun 11; 91(661):417-9. PubMed ID: 6930029 [Abstract] [Full Text] [Related]
14. Diagnosis of susceptibility to malignant hyperthermia in man. Ording H. Br J Anaesth; 1988 Feb 11; 60(3):287-302. PubMed ID: 3279989 [No Abstract] [Full Text] [Related]
19. Malignant hyperthermia in China. Xu ZH, Luo AL, Guo XY, Ren HZ, Wang YL, Zhang X, Huang YG, Ye TH. Anesth Analg; 2006 Oct 11; 103(4):983-5. PubMed ID: 17000816 [Abstract] [Full Text] [Related]
20. Failure of the platelet-halothane nucleotide depletion test as a diagnostic or screening test for malignant hyperthermia. Britt BA, Scott EA. Anesth Analg; 1986 Feb 11; 65(2):171-5. PubMed ID: 3942305 [Abstract] [Full Text] [Related] Page: [Next] [New Search]